Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$291K Buy
2,423
+101
+4% +$11.7K 0.03% 68
2025
Q4
$244K Buy
+2,322
New +$218K 0.03% 73
2025
Q2
Sell
-2,317
Closed -$208K 87
2025
Q1
$208K Buy
2,317
+59
+3% +$5.51K 0.03% 69
2024
Q4
$225K Sell
2,258
-5
-0.2% -$515 0.03% 67
2024
Q3
$257K Buy
2,263
+86
+4% +$10.2K 0.04% 62
2024
Q2
$270K Buy
2,177
+16
+0.7% +$2.06K 0.04% 62
2024
Q1
$285K Buy
2,161
+7
+0.3% +$863 0.05% 61
2023
Q4
$235K Sell
2,154
-22
-1% -$2.28K 0.05% 55
2023
Q3
$224K Buy
2,176
+122
+6% +$13.1K 0.05% 55
2023
Q2
$237K Buy
2,054
+6
+0.3% +$681 0.06% 53
2023
Q1
$218K Sell
2,048
-633
-24% -$68.3K 0.06% 53
2022
Q4
$297K Sell
2,681
-43
-2% -$4.39K 0.09% 47
2022
Q3
$235K Sell
2,724
-36
-1% -$3.21K 0.08% 49
2022
Q2
$252K Buy
2,760
+126
+5% +$11.2K 0.08% 51
2022
Q1
$216K Buy
+2,634
New +$208K 0.06% 57
2021
Q3
Sell
-2,692
Closed -$209K 54
2021
Q2
$209K Sell
2,692
-71
-3% -$5.28K 0.08% 49
2021
Q1
$203K Buy
2,763
+113
+4% +$8.34K 0.08% 54
2020
Q4
$207K Sell
2,650
-16
-0.6% -$1.22K 0.12% 43
2020
Q3
$211K Buy
+2,666
New +$209K 0.13% 42

Other funds holding MRK

Tamar Securities's MRK Position: Q1 2026 in Review

Tamar Securities increased its Merck (MRK) stake by 4.3% in Q1 2026, buying an estimated $11.7K and bringing the position to 2,423 shares worth $291K. The position accounts for 0.03% of the portfolio, ranked #68.

Tamar Securities first reported a position in MRK in Q3 2020 and has held it in 19 quarters since. The position peaked at $297K in Q4 2022. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Tamar Securities held 2,423 shares of Merck worth $291K as of Q1 2026.
  • Tamar Securities bought 101 Merck shares in Q1 2026, an estimated $11.7K.
  • Merck made up 0.03% of Tamar Securities's portfolio in Q1 2026, its #68 holding.
  • Tamar Securities first reported a position in Merck in Q3 2020 and has held it in 19 quarters since.
  • Tamar Securities's Merck position peaked at $297K in Q4 2022.
  • 3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Tamar Securities's 13F filing for Q1 2026, filed 14 May 2026.